- LINKS
-
Global innovation sourcing
Click here for more information about this topic.
-
- Bookmark this page
- gross
Global Innovation Sourcing
Research collaborations are an integral element of our strategy
Collaboration with academic partners is a key component of our innovation strategy. We strongly believe that jointly using the enourmous knowledge which exists in the academic institutions worldwide and the expertise which is available in our company in our key research areas will help us to get a better a understanding of major diseases and to develop better medicines faster.
We are your partner when it comes to discussions about early assets and technologies, for licensing as well as for outpartnering activities. Hereby we embrace innovative approaches in partnership models to find the best solution for both partners. We build on knowledge exchange instead of the classical technology transfer. To strengthen our research network and to establish focussed collaborations we have established innovation sourcing teams in Berlin, Beijing and San Francisco.
More information about our locations
More information about our locations
Tailor-made solutions
There is no one size fits all format for research collaborations. Therefore we have developed a spectrum of partnering models.
- Age-related macular degeneration (AMD)
- Breast cancer
- Central retinal vein occlusion (CRVO)
- Colorectal Cancer (CRC)
- Contraception
- Diabetes
- Diabetic macular edema (DME)
- Endometriosis
- Erectile dysfunction
- Gastrointestinal stromal tumor (GIST)
- Gynecological therapy
- Heart attack
- Heartattack and stroke
- Hemophilia
- High blood pressure
- Infectious diseases
- Liver cancer
- Lung cancer
- Menopausal complaints
- Multiple sclerosis
- Peripheral arterial occlusive disease
- Premenstrual dysphoric disorder (PMDD)
- Prostate cancer
- Pulmonary arterial hypertension
- Renalcell carcinoma
- Stroke
- Testosterone deficiency
- Thrombosis
- Thyroid Cancer
Page tools
- B/W version
- A | A | A | Font size
